Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 102.830 | 102.830 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.550 | 21.523 |
Price to Book | 3.519 | 3.145 |
Price to Sales | 1.966 | 1.700 |
Price to Cash Flow | 14.434 | 11.940 |
Dividend Yield | 1.291 | 1.932 |
5 Years Earnings Growth | 11.722 | 10.230 |
Name | Net % | Category Average |
---|---|---|
Industrials | 69.060 | 58.866 |
Technology | 11.050 | 4.972 |
Utilities | 7.760 | 15.698 |
Healthcare | 4.650 | 9.899 |
Basic Materials | 4.630 | 7.432 |
Real Estate | 1.940 | 1.940 |
Consumer Cyclical | 0.900 | 4.134 |
Number of long holdings: 61
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ebara Corp. | JP3166000004 | 6.93 | 11,990.0 | -8.89% | |
Arcadis | NL0006237562 | 6.79 | 60.60 | +0.25% | |
Stantec | CA85472N1096 | 5.48 | 111.27 | -0.45% | |
Core Main | US21874C1027 | 5.47 | 62.02 | +3.96% | |
Organo Corp | JP3201600008 | 4.97 | 8,260.0 | +1.10% | |
Ingersoll Rand | US45687V1061 | 4.59 | 92.79 | +1.39% | |
GENIVAR Inc. | CA92938W2022 | 4.53 | 217.65 | -0.13% | |
Xylem | US98419M1009 | 4.35 | 143.79 | +1.21% | |
Clean Harbors | US1844961078 | 4.35 | 212.72 | -0.58% | |
Thermo Fisher Scientific | US8835561023 | 3.68 | 598.54 | +0.63% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
OP-Amerikka Indeksi A | 3.5B | 8.82 | 10.79 | 13.92 | ||
OP-Amerikka Indeksi B | 3.5B | 8.82 | 10.78 | 13.92 | ||
OP Amerikka Indeksi II A | 3.5B | 9.39 | 15.07 | 14.37 | ||
OP Amerikka Indeksi II B | 3.5B | 9.38 | 15.07 | 14.37 | ||
OP-Private Strategia 50 A | 2.79B | 3.76 | 3.87 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review